Skip to main content
TipRanks
Go Ultimate75% OFF

Andrew Reardon Insider Profile

11 Followers

Andrew Reardon, CLO & Secretary at Ligand Pharma, holds 31.85K shares in Ligand Pharma (Ticker: LGND).

Andrew Reardon's Trading History

LGND
Ligand Pharma
Nov 04, 2026CLO & SecretaryUninformative Buy261.35K$10.01M
LGND
Insider Shares: 31.85K (0.16%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Nov 04, 2026Uninformative Sell$1.57M5,000$313.21―
Nov 04, 2026Uninformative Buy$261.35K5,000$52.27―
Sep 08, 2026Uninformative Sell$1.43M5,000$286.07―
Aug 04, 2026Uninformative Sell$1.44M5,000$288.98―
Aug 04, 2026Uninformative Buy$261.35K5,000$52.27―

You May Also Like

Andrew Reardon insider profile FAQ

What is the percentage of profitable transactions made by Andrew Reardon?
The percentage of profitable transactions made by Andrew Reardon is 17%.
What is the average return per transaction made by Andrew Reardon?
The average return per transaction made by Andrew Reardon is -68.40%.
What stocks does Andrew Reardon hold?
Andrew Reardon holds: LGND stocks.
What was Andrew Reardon’s latest transaction?
Andrew Reardon’s latest transaction was an Uninformative Buy of $261.35K.
What was Andrew Reardon's most profitable transaction?
Andrew Reardon’s most profitable transaction was an Informative Sell of LGND stock on March 28, 2023. The return on the trade was 0.70%.
What is Andrew Reardon's role in Ligand Pharma?
Andrew Reardon's role in Ligand Pharma is CLO & Secretary.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.